Imatinib mesylate in scleroderma-associated diffuse skin fibrosis: a phase II multicentre randomized double-blinded controlled trial (pages 1138–1144)S. Prey, K. Ezzedine, A. Doussau, A.-S. Grandoulier, D. Barcat, E. Chatelus, E. Diot, C. Durant, E. Hachulla, J.-D. de Korwin-Krokowski, E. Kostrzewa, T. Quemeneur, C. Paul, T. Schaeverbeke, J. Seneschal, A. Solanilla, A. Sparsa, S. Bouchet, S. Lepreux, F.-X. Mahon, G. Chene and A. Taïeb
Article first published online: 5 OCT 2012 | DOI: 10.1111/j.1365-2133.2012.11186.x